• Login
    View Item 
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    Enhancing the Cytotoxic Effect of PARP Inhibitors with DNA Demethylating Agents - A Potential Therapy for Ovarian Cancer?

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Adewuyi_umaryland_0373N_10744.pdf
    Size:
    9.706Mb
    Format:
    PDF
    Download
    Author
    Adewuyi, Adeoluwa Emmanuel
    0000-0002-4454-2683
    Advisor
    Rassool, Feyruz V.
    Date
    2016
    Type
    dissertation
    
    Metadata
    Show full item record
    Abstract
    Ovarian Cancer (OC) is the fifth most common cause of death in women, and the leading cause of gynecological death in the United States. Although some OC patients are responsive to initial treatment (surgery and chemotherapeutic agents such as platinum compounds and taxane), majority of these patients later develop drug resistance and relapse. Initial results of PARP inhibitor (PARPi) therapy in hereditary OC with defects in DNA repair from BRCA1/2 mutations have shown promising results. However, PARPi treatment in OC with intact BRCA1/2 genes has been disappointing. Recent studies have shown that the cytotoxicity of PARPis correlate to its ability to trap PARP in chromatin, with BMN-673 (Talazoparib) demonstrating the most potent trapping activity. Given that DNA methyl transferases (DNMTs) bind PARP and DNMT inhibitors (DNMTi) trap DNMT, we determined whether combination of low, non-cytotoxic doses of the PARPi (Talazoparib) and DNMTi (Azacytidine, 5-AZA) show a significant increase in cytotoxic activity compared to monotherapy with these drugs. We show here that in BRCA1/2-wt OC cells (A2780 and TyKNu), combination treatment with PARPi and DNMTi decreased clonogenicity, in comparison to single agent treatments. In keeping with these findings, we also show that combination therapy leads to increased PARP "trapping" and apoptosis in OC cells. Finally, to develop reagents to test OC more accurately in-vivo, we have generated OC cells with YFP+ luciferase imaging capability, using lentiviral transduction, and determined the optimal conditions in which to test these two drugs in tumor xenografts. Future in-vivo studies with low non-toxic doses of these two drugs will hopefully provide a novel strategy to target OC with intact BRCA1/2 genes, while reducing adverse effects.
    Description
    University of Maryland, Baltimore. Molecular Medicine. M.S. 2016
    Keyword
    DNA methyltransferase inhibitors
    Ovarian Neoplasms--drug therapy
    Poly(ADP-ribose) Polymerase Inhibitors
    Identifier to cite or link to this item
    http://hdl.handle.net/10713/5450
    Collections
    Theses and Dissertations School of Medicine
    Theses and Dissertations All Schools

    entitlement

     
    DSpace software (copyright © 2002 - 2021)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.